Administration of iodinated contrast: What is the risk in cancer patients?

Objective: Despite the association between intravenous contrast and kidney injury, few studies exist in oncology. Our objective was to estimate kidney outcomes following iodinated contrast-enhanced computed tomography (CECT) in cancer patients, and to evaluate whether self-assessment questionnaires can identify kidney injury risk factors.

Methods: This prospective observational study included 289 patients who underwent a CECT scan between March and May 2017 in a hospital setting.